How do I buy prescription medication?

Finadyne for Horses

Finadyne for Horses
Paste » 10g Syringe (Pack of 6)
Solution for Injection » 50ml

Images are for illustration purposes only. Packaging may change from time to time and images on our website may or may not be updated.

  • Paste » 10g Syringe (Pack of 6) £89.50
  • Solution for Injection » 50ml £24.49
  • Solution for Injection » 100ml £46.00

Selection of 3 products from

£24.49 to £89.50

Description

Finadyne is a powerful anti-inflammatory and pain relieving drug, usually used for musculo-skeletal problems and joint injuries in horses. Finadyne also has anti-endotoxic and anti-fever properties, so can be used as an aid in other medical conditions and infections. Finadyne is normally given once daily for up to five days.

Finadyne 50ml/ml Solution for Injection has the following specific indications in cattle, horses and pigs:

Cattle:
The control of acute inflammation associated with respiratory disease, it has also been shown to have some benefit in the treatment of experimental acute bovine pulmonary emphysema (Fog Fever). It can also be used as adjunctive therapy in the treatment of acute mastitis.

Horses:
The alleviation of inflammation and pain associated with musculo-skeletal disorders. It can also be used for the alleviation of visceral pain associated with colic in the horse.

Pigs:
For use as an adjunctive therapy in the treatment of swine respiratory diseases.

Reformulated Finadyne® 50mg/ml Solution for Injection has a shelf life of three years and is available in 50ml and 100ml vials.

Need help or advice? Contact us:

  • Landline: 01582 842096
  • Mon - Fri: 8:30am - 5:00pm
  • Sat: 9:00am - 1:00pm (Collections only)
  • Email: [email protected]

All prices include VAT where applicable.

Medication Datasheets

Paste » 10g Syringe (Pack of 6)

Finadyne 5 % w/w Oral Paste

Qualitative and quantitative composition

Active Ingredient: Flunixin 5.0 % w/w

(as Flunixin meglumine 8.3 % w/w)

For full list of excipients, see section "Pharmaceutical Particulars".

Pharmaceutical form

Oral paste.

White to off-white paste.

Clinical particulars

Target species

Horse

Indications for use

For the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.

Contra-indications

Do not exceed the stated dose or duration of treatment.

Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, or where there is hypersensitivity to the product.

Do not administer other NSAIDs concurrently or within 24 hours of each other.

Do not use in hypovolaemic animals except in the case of endotoxaemia or septic shock.

Avoid use in dehydrated, hypovolaemic or hypersensitive animals as there is a potential risk of increased renal toxicity.

Special warnings for each target species

Non-steroidal anti-inflammatory drugs are not permitted substances under the rules of racing and under rules covering other competitive events. The Royal College of Veterinary Surgeons has given guidance to the Veterinary profession regarding the use of anti-inflammatory drugs in competing horses. It states that if a veterinarian recommends the discontinuation of any such drug not less than eight days before racing he should feel sure he has catered for all but the most exceptional case.

Special precautions for use

Use in animals less than 6 weeks of age or in aged animals may involve additional risk.

If such use cannot be avoided animals may require a reduced dosage and careful clinical management.

It is preferable that flunixin is not administered to animals undergoing general anaesthesia until fully recovered.

NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infections, appropriate concurrent antimicrobial therapy should be instigated.

Special precautions to be taken by the person administering the medicinal product to the animals

Avoid contact with eyes and direct contact with skin. Gloves should be worn during application.

In the case of accidental contact with eyes, rinse immediately with plenty of water and seek medical advice.

The product may cause reactions in sensitive individuals. If you have known hypersensitivity to non-steroidal anti-inflammatory products, do not handle the product. Reactions may be serious.

Wash hands and exposed skin after use.

Adverse reactions

None known.

Use during pregnancy, lactation or lay

Do not administer to pregnant mares. Safety studies in pregnant mares have not been conducted.

Interactions

Concurrent administration of potentially nephrotoxic drugs should be avoided.

Some NSAIDs may be highly bound to plasma proteins and may compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations which can lead to toxic effects.

Amounts to be administered and administration route

For oral administration only.

1.1mg flunixin per kg body weight once daily for up to 5 days according to clinical response.

Each syringe is sufficient for one day’s treatment for a 454kg (1000 lb.) horse. The syringe is calibrated in 100 kg increments to facilitate dosing of horses of different weights.

Overdose

Overdosage studies in the target species have shown the product to be well-tolerated. Flunixin meglumine is a non-steroidal anti-inflammatory drug. Overdosage is associated with gastrointestinal toxicity.

Withdrawal periods

Not to be used in horses intended for human consumption.

Treated horses may never be slaughtered for human consumption.

The horse must have been declared as not intended for human consumption under national horse passport legislation.

Pharmacological particulars

Pharmacodynamic properties

Pharmacotherapeutic group: Anti-inflammatory and anti-rheumatic products, non-steroids

ATC Code: QM01AG90

Flunixin meglumine is a potent non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic activities.

Pharmacokinetic properties

None known.

Pharmaceutical particulars

Excipients

Propylene glycol, Carmellose sodium, Maize Starch and Purified water.

Major incompatibilities

None known.

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 3 years.

Special precautions for storage

Do not store above 25 °C. Do not freeze. Replace cap after use.

Immediate packaging

10g or 30g natural low density white polyethylene syringe barrel and white polypropylene dial-a-dose plunger with low density polyethylene cap and plunger seal.

Not all pack sizes may be marketed.

Disposal

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Marketing Authorisation Number

Vm 01708/4599

Date of the first authorisation or date of renewal

2 February 1989

Date of revision of the text

25 October 2013.

Any other information

For animal treatment only. Keep out of the sight and reach of children.

Legal category

Solution for Injection » 100ml

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF VETERINARY MEDICINAL PRODUCT

    Finadyne 50 mg/ml Solution for Injection

  2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active substance: % w/v Flunixin 5.0 (as Flunixin Meglumine )

Excipients:
Phenol (preservative)            0.50

For the full list of excipients, see section 6.1

  1. PHARMACEUTICAL FORM

    Solution for injection.

  2. CLINICAL PARTICULARS

4.1. Target species

Cattle, horses and pigs.

4.2. Indications for use, specifying the target species

In Cattle:
For the control of acute inflammation associated with respiratory disease.
Finadyne has also been shown to have some benefit in the treatment of experimental acute bovine pulmonary emphysema (Fog Fever).
Finadyne Solution may be used as adjunctive therapy in the treatment of acute mastitis.

In Horses:
For the alleviation of inflammation and pain associated with musculo-skeletal disorders.
For the alleviation of visceral pain associated with colic in the horse.

In Pigs: For use as an adjunctive therapy in the treatment of swine respiratory diseases.

4.3. Contra-indications

Do not exceed the stated dose or the duration of treatment. Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, or where there is hypersensitivity to the product. Do not use the product within 48 hours before expected parturition in cows. Do not administer to pregnant mares. Do not administer to pregnant sows, gilts at mating and in breeding boars.

4.4. Special warning for each target species

Non-steroidal, anti-inflammatory drugs are not permitted under the rules of Racing and under rules covering other competitive events.
The Royal College of Veterinary Surgeons has given advice to the Veterinary Profession regarding the use of anti-inflammatory drugs in competing horses. It states that “if a veterinarian recommends the discontinuation of any such drug not less than eight days before racing, he should feel sure that he has catered for all but the most exceptional case”.
Do not exceed the recommended dose or duration of treatment.

4.5. Special precautions for use

i) Special precautions for use in animals

Avoid intra-arterial injection. NSAIDS are known to have the potential to delay parturition through a tocolytic effect by inhibiting prostaglandins that are important in signalling the initiation of parturition. The use of the product in the immediate post-partum period may interfere with uterine involution and expulsion of foetal membranes resulting in retained placentae. See also section 4.7. Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. Do not use in hypovolaemic animals except in the case of endotoxaemia or septic shock. It is preferable that NSAIDs which inhibit prostaglandin synthesis are not administered to animals undergoing general anaesthesia until fully recovered. The cause of colic should be determined and treated with concurrent therapy. The product should not be used in piglets weighing less than 6 kg.

ii) Special precautions to be taken by the person administering the product to the animal

Avoid contact with skin or eyes.
In case of skin contact, wash exposed area with water.
In case of eye contact, wash eyes thoroughly with clean water and seek medical advice.
Take care against accidental self injection.
Wash hands after use.

4.6. Adverse reactions (frequency and seriousness)

Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID). Untoward effects include gastro-intestinal irritation, ulceration and, in dehydrated or hypovolaemic animals, potential for renal damage.

In pigs transient irritation may occur at the injection site, this resolves spontaneously within 14 days.

4.7. Use during pregnancy, lactation or lay

The product may be used in pregnant and lactating cattle.
The product should only be administered within the first 36 hours post-partum following a benefit/risk assessment performed by the responsible veterinarian and treated animals should be monitored for retained placentae.
Do not use in pregnant mares or pregnant sows. Safety studies in pregnant mares and pregnant sows have not been conducted.

4.8. Interaction with other medicinal products and other forms of interaction

Do not administer other NSAIDs concurrently or within 24 hours of each other.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
Concurrent administration of potentially nephrotoxic drugs should be avoided.

4.9. Amounts to be administered and administration route

Cattle
2ml per 45kg bodyweight (equivalent to 2.2mg flunixin per kg) administered intravenously. Repeat as necessary at 24 hour intervals for up to 5 consecutive days.

Horses
By intravenous injection for musculo-skeletal disorders at the following rate:
1ml per 45kg bodyweight (1.1mg flunixin/kg) once daily for up to 5 days according to clinical response.

By intravenous injection for colic at the following rate:
1ml per 45kg bodyweight (1.1 mg flunixin/kg) repeated once or twice if colic recurs.
For the treatment of endotoxaemia or septic shock associated with gastric torsion and with other conditions in which the circulation of blood to the gastro-intestinal tract is compromised: 0.25mg/kg every 6-8 hours, by intravenous injection.

Pigs
2 ml per 45 kg bodyweight (equivalent to 2.2 mg flunixin/kg) once by intramuscular injection, in the neck, in conjunction with appropriate antimicrobial therapy. The injection volume should be limited to a maximum of 5 ml per injection site.
An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.
When intramuscular injection is used, the dose should be divided between two injection sites on either side of the neck.

In order to prevent excessive broaching of the rubber stopper, it is not recommended that the stopper is broached more than 25 times.

4.10. Overdose (symptoms, emergency procedures, antidotes) if necessary

Overdosage studies in the target species have shown the product to be well-tolerated. Flunixin meglumine is a non-steroidal anti-inflammatory drug. Overdosage is associated with gastrointestinal toxicity. Concurrent use of nephrotoxic drugs should be avoided.

4.11. Withdrawal periods

Animals must not be slaughtered for human consumption during treatment. 
Cattle:      5 days from the last treatment.
Horses:      7 days from the last treatment. 
Pigs:    22 days from the last treatment. 
Milk for human consumption must not be taken during treatment. Milk for human consumption may only be taken from cattle after 24 hours from the last treatment.
  1. PHARMACOLOGICAL PROPERTIES

    Flunixin meglumine is a potent, non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic activities.

  2. PHARMACEUTICAL PARTICULARS

6.1. List of excipients

Phenol 
Sodium phosphate tribasic dodecahydrate
Edentate disodium
Sodium formaldehyde sulfoxylate Propylene glycol
Sodium hydroxide
Water for injection

6.2. Major incompatibilities

Do not administer other NSAIDs concurrently or within 24 hours of each other.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
Concurrent administration of potential nephrotoxic drugs should be avoided.

6.3. Shelf-life

3 years
Following withdrawal of the first dose, use within 28 days.
Discard unused material.

6.4. Special precautions for storage

Do not store above 25°C.
Do not freeze.

6.5. Nature and composition of immediate packaging

Pack Sizes: 50 ml and 100 ml vials. Containers: Clear Type I glass vials, moulded. Closures: Chlorobutyl rubber stopper with flip-off cap.

6.6. Special precautions for the disposal of unused product or waste material

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
  1. MARKETING AUTHORISATION HOLDER

Intervet UK Ltd Walton Manor Walton Milton Keynes Buckinghamshire MK7 7AJ

  1. MARKETING AUTHORISATION NUMBER

    Vm 01708/4582

  2. DATE OF FIRST AUTHORISATION

    27 August 1987

  3. DATE OF LAST REVISION

    June 2019

    Approved: 28 June 2019

Solution for Injection » 50ml

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF VETERINARY MEDICINAL PRODUCT

    Finadyne 50 mg/ml Solution for Injection

  2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active substance: % w/v Flunixin 5.0 (as Flunixin Meglumine )

Excipients:
Phenol (preservative)            0.50

For the full list of excipients, see section 6.1

  1. PHARMACEUTICAL FORM

    Solution for injection.

  2. CLINICAL PARTICULARS

4.1. Target species

Cattle, horses and pigs.

4.2. Indications for use, specifying the target species

In Cattle:
For the control of acute inflammation associated with respiratory disease.
Finadyne has also been shown to have some benefit in the treatment of experimental acute bovine pulmonary emphysema (Fog Fever).
Finadyne Solution may be used as adjunctive therapy in the treatment of acute mastitis.

In Horses:
For the alleviation of inflammation and pain associated with musculo-skeletal disorders.
For the alleviation of visceral pain associated with colic in the horse.

In Pigs: For use as an adjunctive therapy in the treatment of swine respiratory diseases.

4.3. Contra-indications

Do not exceed the stated dose or the duration of treatment. Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, or where there is hypersensitivity to the product. Do not use the product within 48 hours before expected parturition in cows. Do not administer to pregnant mares. Do not administer to pregnant sows, gilts at mating and in breeding boars.

4.4. Special warning for each target species

Non-steroidal, anti-inflammatory drugs are not permitted under the rules of Racing and under rules covering other competitive events.
The Royal College of Veterinary Surgeons has given advice to the Veterinary Profession regarding the use of anti-inflammatory drugs in competing horses. It states that “if a veterinarian recommends the discontinuation of any such drug not less than eight days before racing, he should feel sure that he has catered for all but the most exceptional case”.
Do not exceed the recommended dose or duration of treatment.

4.5. Special precautions for use

i) Special precautions for use in animals

Avoid intra-arterial injection. NSAIDS are known to have the potential to delay parturition through a tocolytic effect by inhibiting prostaglandins that are important in signalling the initiation of parturition. The use of the product in the immediate post-partum period may interfere with uterine involution and expulsion of foetal membranes resulting in retained placentae. See also section 4.7. Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. Do not use in hypovolaemic animals except in the case of endotoxaemia or septic shock. It is preferable that NSAIDs which inhibit prostaglandin synthesis are not administered to animals undergoing general anaesthesia until fully recovered. The cause of colic should be determined and treated with concurrent therapy. The product should not be used in piglets weighing less than 6 kg.

ii) Special precautions to be taken by the person administering the product to the animal

Avoid contact with skin or eyes.
In case of skin contact, wash exposed area with water.
In case of eye contact, wash eyes thoroughly with clean water and seek medical advice.
Take care against accidental self injection.
Wash hands after use.

4.6. Adverse reactions (frequency and seriousness)

Flunixin meglumine is a non-steroidal anti-inflammatory drug (NSAID). Untoward effects include gastro-intestinal irritation, ulceration and, in dehydrated or hypovolaemic animals, potential for renal damage.

In pigs transient irritation may occur at the injection site, this resolves spontaneously within 14 days.

4.7. Use during pregnancy, lactation or lay

The product may be used in pregnant and lactating cattle.
The product should only be administered within the first 36 hours post-partum following a benefit/risk assessment performed by the responsible veterinarian and treated animals should be monitored for retained placentae.
Do not use in pregnant mares or pregnant sows. Safety studies in pregnant mares and pregnant sows have not been conducted.

4.8. Interaction with other medicinal products and other forms of interaction

Do not administer other NSAIDs concurrently or within 24 hours of each other.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
Concurrent administration of potentially nephrotoxic drugs should be avoided.

4.9. Amounts to be administered and administration route

Cattle
2ml per 45kg bodyweight (equivalent to 2.2mg flunixin per kg) administered intravenously. Repeat as necessary at 24 hour intervals for up to 5 consecutive days.

Horses
By intravenous injection for musculo-skeletal disorders at the following rate:
1ml per 45kg bodyweight (1.1mg flunixin/kg) once daily for up to 5 days according to clinical response.

By intravenous injection for colic at the following rate:
1ml per 45kg bodyweight (1.1 mg flunixin/kg) repeated once or twice if colic recurs.
For the treatment of endotoxaemia or septic shock associated with gastric torsion and with other conditions in which the circulation of blood to the gastro-intestinal tract is compromised: 0.25mg/kg every 6-8 hours, by intravenous injection.

Pigs
2 ml per 45 kg bodyweight (equivalent to 2.2 mg flunixin/kg) once by intramuscular injection, in the neck, in conjunction with appropriate antimicrobial therapy. The injection volume should be limited to a maximum of 5 ml per injection site.
An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.
When intramuscular injection is used, the dose should be divided between two injection sites on either side of the neck.

In order to prevent excessive broaching of the rubber stopper, it is not recommended that the stopper is broached more than 25 times.

4.10. Overdose (symptoms, emergency procedures, antidotes) if necessary

Overdosage studies in the target species have shown the product to be well-tolerated. Flunixin meglumine is a non-steroidal anti-inflammatory drug. Overdosage is associated with gastrointestinal toxicity. Concurrent use of nephrotoxic drugs should be avoided.

4.11. Withdrawal periods

Animals must not be slaughtered for human consumption during treatment. 
Cattle:      5 days from the last treatment.
Horses:      7 days from the last treatment. 
Pigs:    22 days from the last treatment. 
Milk for human consumption must not be taken during treatment. Milk for human consumption may only be taken from cattle after 24 hours from the last treatment.
  1. PHARMACOLOGICAL PROPERTIES

    Flunixin meglumine is a potent, non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic activities.

  2. PHARMACEUTICAL PARTICULARS

6.1. List of excipients

Phenol 
Sodium phosphate tribasic dodecahydrate
Edentate disodium
Sodium formaldehyde sulfoxylate Propylene glycol
Sodium hydroxide
Water for injection

6.2. Major incompatibilities

Do not administer other NSAIDs concurrently or within 24 hours of each other.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
Concurrent administration of potential nephrotoxic drugs should be avoided.

6.3. Shelf-life

3 years
Following withdrawal of the first dose, use within 28 days.
Discard unused material.

6.4. Special precautions for storage

Do not store above 25°C.
Do not freeze.

6.5. Nature and composition of immediate packaging

Pack Sizes: 50 ml and 100 ml vials. Containers: Clear Type I glass vials, moulded. Closures: Chlorobutyl rubber stopper with flip-off cap.

6.6. Special precautions for the disposal of unused product or waste material

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
  1. MARKETING AUTHORISATION HOLDER

Intervet UK Ltd Walton Manor Walton Milton Keynes Buckinghamshire MK7 7AJ

  1. MARKETING AUTHORISATION NUMBER

    Vm 01708/4582

  2. DATE OF FIRST AUTHORISATION

    27 August 1987

  3. DATE OF LAST REVISION

    June 2019

    Approved: 28 June 2019

Delivery Information

How quickly do you deliver?

Under almost all products on our website is an Estimated dispatch time, check this for a delivery prediction specific to the item you are looking to purchase. These badges are updated live based on the stock levels we have and also those of our suppliers - so are usually very accurate, but cannot be guaranteed. In more general terms, we aim to dispatch all orders within 1 working day of receiving payment (and a prescription if required). If we cannot do so within 3 working days we will contact you by email.

What do you charge for delivery?

For UK delivery, we charge the following:

Order Total Weight Delivery
£0-£28.99 Under 2kg £2.99
2kg+ £4.99
£29-£38.99 Under 2kg Free
2kg+ £4.99
£39+ Under 2kg Free
2kg+ Free

Prices quoted are for delivery to all parts of mainland UK except certain Scottish postcodes (where the price is higher for items sent by courier. Delivery of food abroad (including Channel Islands, N. Ireland and other islands around the UK) is charged at a higher price and free delivery is not available. Temperature controlled products are also not always subject to the standard and/or free delivery options.

For full information on our delivery charges, including prices on heavy deliveries to Scotland and abroad, see our delivery information page.

We can deliver most items to all around the world, but prices do vary. To find the exact cost of shipping your item, and to see all options available, follow these steps:

  1. Put the items you wish to order in your basket
  2. Proceed to checkout and enter your delivery address, including country
  3. Delivery information including price will automatically update to what is available to you

Delivery of aerosols

Due to restrictions aerosols can't be sent by Royal Mail. We appreciate your understanding.

Delivery of temperature controlled items

Some products, such as non-ambient items and frozen food, need to be delivered in insulated packaging to prevent them from getting too warm (or too cold) during transit from us to you. Purchasing any of these items in your order will result in a £1.99 charge being added to the total to cover the high cost of the insulated packaging materials. You only pay the £1.99 once per order, regardless of how many temperature controlled items you purchase in that order.

How do I cancel or return an order?

Please call us as soon as possible if you need to amend or cancel an order on 01582 842096. If your order has been processed for dispatch we will be unable to cancel or amend the order. You will however be able to return your product for a full refund*.

To return an item, you must contact us by phone or email to arrange this BEFORE posting any product back to us. We will explain the process at this stage for you.

*For full details on returns, see our terms and conditions page.

Reviews (1)

Q & A

There are currently no questions for Finadyne for Horses - be the first to ask one!